VANCOUVER, BC / ACCESSWIRE / March 3, 2022 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused on ...

Psychedelic drug company NeonMind Biosciences Inc. NEONNMDBF(FRA:6UF) announced Thursday a strategic partnership with BioScript Solutions, a Canadian leader in specialty care. Under the terms of the ...

Bioscript was founded to solve a specific problem. In 2001, a research study of a drug delivered by infusion—that is, directly into the bloodstream via IV—was being conducted at a New Brunswick ...

Lisa Matar will lead BioScript Solutions into the next stage of growth. "We're thrilled to [welcome] Lisa Matar as the first Chief Executive Officer at BioScript Solutions," said David Ford, ...

Bioscript Group, a global medical communications and strategy partner, supporting pharma and biotech companies in delivering impactful scientific engagement across the product lifecycle, has announced ...

TORONTO, ONTARIO--(Marketwired - Sep 24, 2013) - Symbility Health Inc., a division of Symbility Solutions Inc. (TSX VENTURE:SY)(ATBEF), is pleased to confirm a contract with BioScript Pharmacy, a ...

Third-party logistics service offers Canadian gateway for global pharma and biotech companies TORONTO, Sept. 1, 2020 /CNW/ - BioScript Solutions, a company dedicated to providing full-service ...

Macclesfield, UK - 30th April 24 - Bioscript Group, a leading provider of medical communications, market access, and regulatory writing services, has today announced the acquisition of science ...

The addition of the two specialist global providers extends the breadth and depth of Bioscript services across the pharmaceutical product lifecycle: with additional capabilities in medical affairs, ...

Forbes does not accept payment for placement on lists.